Merck & Co (MRK)
62.60
-0.34 -0.54%
NYSE
Jul 21, 16:33
Delayed 2m
USD
Merck & Co Shareholders Equity (Quarterly):
39.84B for March 31, 2017View 4,000+ financial data types
Browse...
View Full Chart
Merck & Co Shareholders Equity (Quarterly) Chart
Export Data
Save Image
Print Image
For advanced charting, view our full-featured
Fundamental Chart
Merck & Co Historical Shareholders Equity (Quarterly) Data
View and export this data going back to 1984.
Start your Free Trial
Export Data
Date Range:
| Data for this Date Range | |
|---|---|
| March 31, 2017 | 39.84B |
| Dec. 31, 2016 | 40.09B |
| Sept. 30, 2016 | 43.74B |
| June 30, 2016 | 43.36B |
| March 31, 2016 | 43.81B |
| Dec. 31, 2015 | 44.68B |
| Sept. 30, 2015 | 45.59B |
| June 30, 2015 | 46.45B |
| March 31, 2015 | 47.76B |
| Dec. 31, 2014 | 48.65B |
| Sept. 30, 2014 | 45.22B |
| June 30, 2014 | 48.36B |
| March 31, 2014 | 49.98B |
| Dec. 31, 2013 | 49.76B |
| Sept. 30, 2013 | 47.42B |
| June 30, 2013 | 47.50B |
| March 31, 2013 | 53.03B |
| Dec. 31, 2012 | 53.02B |
| Sept. 30, 2012 | 55.75B |
| June 30, 2012 | 55.19B |
| March 31, 2012 | 54.86B |
| Dec. 31, 2011 | 54.52B |
| Sept. 30, 2011 | 55.14B |
| June 30, 2011 | 55.50B |
| March 31, 2011 | 54.38B |
| Dec. 31, 2010 | 54.38B |
| Sept. 30, 2010 | 55.59B |
| June 30, 2010 | 55.23B |
| March 31, 2010 | 57.88B |
| Dec. 31, 2009 | 59.06B |
| Sept. 30, 2009 | 22.91B |
| June 30, 2009 | 20.32B |
| March 31, 2009 | 19.56B |
| Dec. 31, 2008 | 18.76B |
| Sept. 30, 2008 | 19.57B |
| June 30, 2008 | 20.26B |
| March 31, 2008 | 19.52B |
| Dec. 31, 2007 | 18.18B |
| Sept. 30, 2007 | 20.72B |
| June 30, 2007 | 19.47B |
| March 31, 2007 | 18.48B |
| Dec. 31, 2006 | 17.56B |
| Sept. 30, 2006 | 19.29B |
| June 30, 2006 | 19.30B |
| March 31, 2006 | 18.85B |
| Dec. 31, 2005 | 17.98B |
| Sept. 30, 2005 | 17.78B |
| June 30, 2005 | 17.39B |
| March 31, 2005 | 17.65B |
| Dec. 31, 2004 | 17.29B |
There is no data for the selected date range.
An error occurred. Please try again by refreshing your browser or contact us with details of your problem.
About Shareholders' Equity
Shareholders' equity is difference between a company's total assets and total liabilities. Also referred to as stockholders' equity, net worth, or net assets.
Learn More
Advertisement
MRK Shareholders Equity (Quarterly) Benchmarks
| Companies | |
|---|---|
| Celgene | 7.644B |
| Johnson & Johnson | 70.34B |
| Eli Lilly | 14.03B |
MRK Shareholders Equity (Quarterly) Range, Past 5 Years
| Minimum | 39.84B | Mar 2017 |
| Maximum | 55.75B | Sep 2012 |
| Average | 47.05B |
MRK Shareholders Equity (Quarterly) Excel Add-In Codes
- Metric Code: shareholders_equity
- Latest data point: =YCP("MRK", "shareholders_equity")
- Last 5 data points: =YCS("MRK", "shareholders_equity", -4)
To find the codes for any of our financial metrics, see our Complete Reference of Metric Codes.
Access our powerful Excel Add-in with a YCharts Professional Membership. Learn More.
MRK News
Merck Says EU Committee Adopts Positive Opinion, Recommends Approval of Keytruda For Bladder Cancer
MT Newswires 07/21 08:53 ET
MT Newswires 07/21 08:53 ET
Pharma Stock Roundup: J&J, NVS' Q2 Earnings, Merck Drug Gets Tentative FDA Nod
Yahoo 07/21 08:35 ET
Yahoo 07/21 08:35 ET
Advertisement
